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The identity of a peptidase activity with human serum pseudocholinesterase (PsChE) purified to apparent 
homogeneity was demonstrated by (a) co-elution of both peptidase and PsChE activities from procainamide- 
Sepharose and concanavalin-A - Sepharose affinity chromatographic columns; (b) comigration on polyacryl- 
amide gel electrophoresis; (c) co-elution on Sephadex G-200 gel filtration and (d) coprecipitation at different 
dilutions of an antibody raised against purified PsChE. The purified enzyme showed a single protein band on gel 
electrophoresis under non-denaturing conditions. SDS gel electrophoresis under reducing conditions, followed 
by silver staining, also gave a single protein band (MI x 90000). Peptidase activity using different peptides showed 
the release of C-terminal amino acids. Blocking the carboxy terminal by an amide or ester group did not prevent 
the hydrolysis of peptides. There was no evidence for release of N-terminal amino acids. 
Potent anionic or esteratic site inhibitors of PsChE, such as eserine sulphate, neostigmine, procainamide, 
ethopropazine, imipramine, diisopropylfluorophosphate, tetra-isopropylpyrophosphoramide and phenyl boronic 
acid, did not inhibit the peptidase activity. An anionic site inhibitor (neostigmine or eserine) in combination with 
an esteratic site inhibitor (diisopropylfluorophosphate) also did not inhibit the peptidase. However, the choline 
esters (acetylcholine, butyrylcholine, propionylcholine, benzoylcholine and succinylcholine) markedly inhibited 
the peptidase activity in parallel to PsChE. Choline alone or in combination with acetate, butyrate, propionate, 
benzoate or succinate did not significantly inhibit the peptidase activity. It appeared that inhibitor compounds 
which bind to both the anionic and esteratic sites simultaneously (like the substrate analogues choline esters) 
could inhibit the peptidase activity possibly through conformational changes affecting a peptidase domain. 
Human serum pseudocholinesterase (PsChE) is a tetramer 
with a subunit MI of 90000 [l]. It has four identical subunits, 
two monomers covalently linked through a single disulfide 
bond into a dimer and two such dimers hydrophobically 
linked into a tetramer [2]. It is a less complex protein than 
acetylcholinesterase (AChE) from several sources [3 - 61. 
However, there are several features common to PsChE and 
AChE. PsChE exhibits a serotonin-sensitive aryl acylamidase 
activity similar to AChE from diverse sources [7 - 101. It bears 
a limited homology in its active-site amino acid sequence to 
AChE and some serine proteases [ll]. Based on several lines 
of evidence it has been speculated that the cholinesterases may 
have more than one function [12, 131. 
The hydrolysis of substance P by purified human serum 
PsChE was demonstrated by Lockridge [14] and Masson [15]. 
The cleavage products from substance P by the action of 
PsChE indicated the involvement of a dipeptidyl peptidase 
and a deamidase-like activity [14]. Nausch and Heymann [I61 
showed that the dipeptidyl peptidase activity was a con- 
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Abbreviations. PsChE, pseudocholinesterase; AChE, acetyl- 
cholinesterase; Dip-F, diisopropylfluorophosphate; SDS, sodium 
dodecyl sulfate. 
Enzymes. Pseudocholinesterase or butyrylcholinesterase or 
cholinesterase or acylcholine acylhydrolase (EC 3.1.1.8); acetyl- 
cholinesterase or acetvlcholine acetvlhvdrolase or true cholinesterase - .  
(EC 3.1.1.7). 
taminant present in the purified PsChE and suggested that 
the deamidase-like activity might be associated with the serum 
PsChE. 
In the present work we have made a systematic study to 
establish the identity of a peptidase activity with human serum 
PsChE purified to apparent homogeneity. We also describe 
the nature of this peptidase and its inhibition characteristics 
in comparison to PsChE. 
MATERIALS AND METHODS 
Materials 
Various amino acids, peptides, o-phthalaldehyde, butyryl- 
thocholine iodide, procainamide HC1, ethopropazine, imi- 
pramine, tetra-isopropylpyrophosphoramide, phenyl boronic 
acid, choline and choline esters were obtained from Sigma 
Chemical Co. (St Louis, USA). Sephadex G-200 was obtained 
from Pharmacia Fine Chemicals (Uppsala, Sweden). All other 
chemicals and solvents were of high grade purity or procured 
as described earlier [17]. Ethyl esters of peptides were prepared 
by bubbling dry HCl gas through the peptides (2 mg) in 0.5 ml 
absolute ethanol for 45 min [18]. N-Acetyl-[Met’lenkephalin 
was prepared by acetylation of [Met’lenkephalin with acetic 
anhydride in NaHC03 solution under nitrogen according to 
George and Balasubramanian [19]. Diisopropylfluorophos- 
phate (Dip-F) was a kind gift from Dr K. S. Krishnan, Tata 
Institute of Fundamental Research, Bombay. 
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Concanavalin-A - Sepharose and lysine-Sepharose were 
prepared by coupling concanavalin A or lysine to cyanogen- 
bromide-activated Sepharose 4B [20] according to methods 
described earlier [21, 221. Procainamide was coupled to 
Sepharose through a ten-carbon spacer arm [lo, 171. Zn2+ 
and Co2 +-chelated iminodiacetic-acid - Sepharose was pre- 
pared as described by Porath et al. [23]. 
Purification of the PsChE 
PsChE was purified by the procedure described earlier 
[17] involving the use of a procainamide-Sepharose affinity 
column twice. The enzyme eluted from the first procainamide- 
Sepharose chromatography with NaCl, after dialysis it was 
rechromatographed and eluted with 0.05 M procainamide in 
20 mM potassium phosphate buffer, pH 7.0. The active 
fractions were pooled and used in further studies. 
Chromatography on other affinity gels 
The purified enzyme (1 ml) was applied on to a con- 
canavalin-A - Sepharose column (4 x 0.5 cm) pre-equili- 
brated with 20 mM sodium acetate buffer, pH 5.0, washed 
with the same buffer and eluted with 0.5 M methyl ol-glucoside 
in the equilibrating buffer. The lysine-Sepharose column 
(4 x 0.5 cm), equilibrated with 20 mM potassium phosphate 
buffer pH 7.0, was washed with the same buffer and eluted 
with 0.6 M NaCl in the equilibrating buffer. In the case of 
Zn2+ and Co2+-chelated Sepharose columns (4 x 0.5 cm) the 
equilibration and washing were done with 20 mM potassium 
phosphate buffer, pH 7.0, and elution with 10 mM imidazole 
in the equilibrating buffer. 
Polyacrylamide gel electrophoresis 
Polyacrylamide gel electrophoresis of the purified enzyme 
(8 pg) was carried out according to Davis [24] in Tris/glycine 
buffer, pH 8.3, in tubes with 7% acrylamide. After electropho- 
resis the gels were either stained by Coomassie brilliant blue 
G or assayed for enzyme activities as follows. The gels were 
cut into slices of 2.0 mm thickness, extracted in 0.4 ml20 mM 
potassium phosphate buffer pH 7.0 overnight, dialysed 
against the same buffer to remove Tris/glycine and assayed 
for PsChE and peptidase activity using suitable aliquots. SDS 
gel electrophoresis of the purified enzyme under reducing 
and non-reducing conditions [17] was carried out in 10% 
acrylamide slab gels according to Laemmli [25], which were 
stained with silver nitrate in an alkaline medium in the pres- 
ence of formaldehyde [26]. Standard marker proteins used 
were immunoglobulin (MI 150000), bovine serum albumin 
(MI 68000), ovalbumin ( M ,  45000) and myoglobin ( M ,  
17800). 
Sephadex G-200 gel filtration 
The concentrated purified enzyme (0.5 ml) was applied on 
a Sephadex G-200 gel filtration column (35 x 0.7 cm) pre- 
equilibrated with 20 mM potassium phosphate buffer, pH 7.0, 
containing 0.5 M NaCI. The enzyme was eluted by the same 
buffer at a flow rate of 2.7 ml/h and fractions of 1 ml were 
collected. Each fraction, after dialysis against the phosphate 
buffer, was assayed for both enzyme activities. 
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Fig. 1. Affinity chromatographic elution profile of PsChE (0-0) 
and peptidase activity from the procainamide-Sepharose column b-v 
0.05 M procainamide in buffer. The peptidase activity was mea- 
sured by the o-phthalaldehyde fluorimetric method using Phe-Leu 
(0-0) and [Leu'lenkephalin (0-0) as substrate. Details 
of the chromatography are described in Materials and Methods 
Immunological studies 
Anti-PsChE serum was raised in a rabbit and purified 
by DEAE-cellulose chromatography as described earlier [ 101. 
The purified antibody was free of any detectable PsChE or 
peptidase activity. Immunoprecipitation was done by cross- 
reacting different dilutions (0.03 -0.5 mg) of antibody with 
the purified enzyme (0.004 mg) in 0.4 ml 20 mM potassium 
phosphate buffer, pH 7.2, followed by incubation at 4°C 
overnight. After centrifugation of the mixture at 10000 x g 
for 30 min the PsChE and peptidase activities were determined 
in the supernatant. 
Enzyme assay and protein estimation 
PsChE activity was assayed with butyrylthiocholine iodide 
as substrate according to Ellman et al. [27]. 1 unit of PsChE 
activity was defined as the absorbance change of l/min at 
412 nm under standard assay conditions. The peptidase activi- 
ty was assayed in 50 mM potassium phosphate buffer, pH 7.2, 
using 400 pM of either Phe-Leu or [Leu'lenkephalin as sub- 
strate and 0.1 ml enzyme (4 pg) in a total volume of 0.2 ml 
reaction mixture. After incubation at 37 "C for different time 
periods of up to 6 h the reaction mixture was heated in a 
boiling water bath for 1 min and the peptidase activity was 
measured by the released amino acids as determined by the 
o-phthalaldehyde fluorimetric method [28]. Briefly, to 0.05 - 
0.1 ml reaction mixture, 0.3 ml o-phthalaldehyde reagent 
(2 mg o-phthalaldehyde/0.2 ml ethanol mixed with 2 p1 2- 
mercaptoethanol/0.2ml ethanol and made up to 12ml in 
50 mM borate buffer, pH 9.5) was added in a final volume of 
0.4ml. Fluorescence was measured in a Hitachi spectro- 
fluorimeter (model 204-A) using an excitation wavelength of 
345 nm and an emission wavelength of 455 nm. The amount 
of the substrate (for Phe-Leu) hydrolysed was determined 
from a standard curve obtained with known concentrations 
of an equimolar mixture of phenylalanine and leucine. 1 unit 
of peptidase activity is defined as 1 nmol each of 
phenylalanine and leucine liberated/h. 
Protein was determined according to Lowry et al. [29] with 
crystalline bovine serum albumin as standard or by ab- 
sorbance at 280 nm (for column effluents). 
Paper chromatography 
One dimensional paper chromatography (descending) on 
Whatman no. 1 paper was done using the solvent system 
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Fig. 2. Polyacrylamide gel electrophoresis of the purijied PsChE and the activity profile of the enzyme extracted from gel slices. Enzyme activities 
were measured using the substrate butyrylthiocholine (0-0) for PsChE and Phe-Leu (0-0) and [Leu’lenkephalin (O----O) 
for the peptidase. Details of the electrophoresis and assay procedure are given in Materials and Methods 
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Fig. 3.  Sephadex G-200 gelfiltration of the purijied enzyme and elution 
profile of PsChE and peptidase activities. Each fraction was assayed 
for PsChE (0-0) and peptidase using Phe-Leu (0-0) or 
[Leu’lenkephalin (0-0) as substrate. Details of chromatog- 
raphy and assay procedures are given in Materials and Methods. 
Arrows indicate the elution peaks of (a) blue dextran, (b) immuno- 
globulin (150000), (c) bovine serum albumin (68000) and (d) 
ovalbumin (45 000) 
butanol/acetic acid/water (4/1/1 v/v/v). The spots were devel- 
oped by spraying with ninhydrin (0.4% w/v) in acetone and 
warming the paper at 70°C for 5 min. 
RESULTS 
Binding and co-elution of PsChE and peptidase activity 
in various affinity column chromatographic procedures 
The elution profiles of PsChE and peptidase activities of 
the purified enzyme from the procainamide-Sepharose affinity 
column chromatographic procedure is shown in Fig. 1. Both 
enzyme activities were bound 100% to the column and co- 
eluted and the ratios of the two activities were similar in all 
the active fractions. 
In order to verify the identical behaviour of the PsChE and 
peptidase activities the purified enzyme was passed through 
different types of affinity columns. Both the enzyme activities 
A B  
Fig. 4. SDSlpolyacrylamide gel electrophoresis of the purified enzyme 
(8 pgj under reducing ( A )  and non-reducing conditions ( B ) .  The pro- 
tein bands were stained with silver nitrate. Details of electrophoresis 
and staining procedures are given in Materials and Methods. Arrows 
b and respectively indicate the dimeric and monomeric forms of 
the enzyme 
were completely bound to a concanavalin-A - Sepharose 
column, indicating the glycoprotein nature of the enzyme, and 
were co-eluted more than 90% with methyl a-glucoside in 
buffer. Both enzymes bound to a lysine-Sepharose column 
and were completely elutable with NaCl. ZnZf and Co2+ 
metal chelate columns did not bind both enzyme activities. 
Comigration on polyacrylamide gel electrophoresis 
Fig. 2 shows the gel electrophoresis pattern of the purified 
enzyme under non-denaturing conditions and the profile of 
the enzyme activities in the gel slices. A single protein band, 
which corresponded to both PsChE and peptidase activities, 
was observed indicating comigration of both activities. 
Sephadex G-200 gel filtration 
The Sephadex G-200 gel filtration pattern of the purified 
enzyme is shown in Fig. 3. The elution profile showed that 
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Fig. 5 .  Immunoprecipitation of PsChE (0-0) and peptidase 
activities at different dilutions of the antibody raised against purified 
PsChE. Peptidase was assayed using Phe-Leu (0-@) or [LeuS]- 
enkephalin (0-0) as substrate. Details of the experiment are 
given under Materials and Methods 
Incubation time (houri 
Fig. 6. The degradation of Phe-Leu (0-0) and 
[Leu’Jenkeplialin (0--0) by the peptidase activity of PsChE at 
different time intervals of incubation. The amino acids released from 
the peptides were monitored by the o-phthalaldehyde fluonmetric 
method. Details of the assay procedures are given in Materials and 
Methods 
both PsChE and peptidase activities co-eluted as a single peak 
from the column. From the elution pattern of marker proteins 
the relative molecular mass of the native enzyme was 
calculated to be approximately 1 70000 corresponding to the 
dimeric form of PsChE. The ratio of PsChE to peptidase 
activity remained approximately constant in all the eluted 
fractions. 
SDS gel electrophoresis 
The SDS gel electrophoretic pattern of the purified enzyme 
under reducing and non-reducing conditions is shown in 
Fig. 4. Under non-reducing conditions protein bands cor- 
responding to both the monomeric and dimeric forms of 
enzyme appeared, whereas under reducing condition only the 
monomeric form (Mr x 90000) was seen. 
Immunoprecipitation studies 
Immunoprecipitation of the purified enzyme showed that 
both the peptidase and PsChE activities could be co- 
precipitated by the purified antibody. The ratio of peptidase 
to PsChE activity precipitated at different dilutions of the 
Table 1. Release of amino ac ih  from various peptides by the peptidase 
associated with PsChE 
Each substance at a concentration of 400 pM was incubated with 4 pg 
enzyme in a total volume of 0.2ml potassium phosphate buffer, 
pH 7.2, for 4 h at 37°C. Liberated amino acids were identified by 
paper chromatography as described in Materials and Methods 
Peptide substrate used Amino acids 
released 
Phe, Leu Phe-Leu 
[LeuS]Enkephalin (Tyr-Gly-Gly-Phe-Leu) Leu, Phe 
[MetS]Enkephalin (Tyr-Gly-Gly-Phe-Met) Met, Phe 
Tyr-Gly-Gly not detectable 
N- Acetyl-[ Met S]enkephalin Met, Phe 
Phe-LeuNH2 Phe. Leu 
Phe-Leu ethyl ester Phe, Leu 
[Leu’IEnkephalin ethyl ester Leu, Phe 
N-Acetyl-[Met’lenkephalin ethyl ester Met, Phe 
Substance P 
(Arg-Pro- Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu- 
MetNH2) Met, Leu 
(Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe- Arg) Arg, Phe 
(Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu) Leu 
(Tyr-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg) Arg, Phe 
Bradykinin 
Angiotensin I 
Tyr-bradykinin 
Characterization o j  the peptidase associated with PsChE 
The peptidase activity in the purified enzyme was labile to 
freezing and thawing, as was PsChE (300% loss of peptidase 
and 82% loss of PcChE after two freezing and thawing). The 
activity was linear up to 4 h for hydrolysis of either Phe- 
Leu or [Leu’lenkephalin (Fig. 6). A Lineweaver-Burk plot 
for hydrolysis of Phe-Leu and [Leu’lenkephalin showed K ,  
values of 303 pM and 211 pM respectively. The peptidase 
activity was inhibited 55-65% by 1 mM Cd2+, Co2+ or 
Zn2’. EDTA inhibited the peptidase 50 - 15% in the concen- 
tration range of 0.1 - 1 mM (data not shown). The inhibitory 
effect of EDTA was verified by paper chromatography of the 
reaction mixtures using different peptides as substrate. 
The products released by the peptidase from various 
peptide substrates, as identified by paper chromatography, 
are given in Table 1. From both [Leu’lenkephalin and 
[Met’lenkephalin only two amino acids from the carboxy 
terminal, namely Leu and Phe or Met and Phe, were released. 
This was also verified in separate experiments by subjecting 
the reaction mixtures, incubated for periods from 30 min to 
4 h to paper chromatography. Tyr-Gly-Gly was a poor sub- 
strate and did not show any release of amino acids. Blocking 
the N-terminal by an acetyl group, as in N-acetyl- 
[Met5]enkephalin, also gave the two C-terminal amino acids 
released. Surprisingly blocking the C-terminal amino acid by 
an amide or ester group did not prevent the release of 
the amino acids as in Phe-LeuNH2, Phe-Leu ethyl ester, 
[Leu’lenkephalin ethyl ester or N-acetyl-[Met5]enkephalin 
ethyl ester. 
Use of other peptide substrates like substance P, brady- 
kinin, angiotensin I and Tyr-bradykinin also resulted in the 
release of C-terminal amino acids (Table 1). Gly, His and Pro 
appeared to be unfavourable amino acids to be released. 
Inhibition characteristics 
Potent inhibitors of PsChE. like ethoDroDazine. imi- 
I .  
antibody was constant (Fig. 5). pramine, eserine sulphate, neostigmine, Dip-F, tetra-isopro- 
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Table 2. Effect of PsChE inhibitors on peptidase activity 
Peptidase activity was assayed fluorimetrically as given in Materials 
and Methods using Phe-Leu (400 kM) as substrate for 4 h at 37°C in 
potassium phosphate buffer, pH 7.2. In the control reaction mixture 
the inhibitors were added after arresting the reaction. The inhibition 
pattern was also confirmed qualitatively by paper chromatography 
(data not shown). Results are given as percentage of the control 
activity 
~~~ ~ ~ 
Inhibitor Concen- Activity 
tration 
PsChE peptidase 
mM YO 
Eserine sulphate 
Neostigmine 
Procainamide 
Ethopropazine 
Imipramine 
Diisopropylfluorophosphate 
Tetra-isopropylpyrophosphoramide 
Phenyl boronic acid 
Eserine sulphate 
Neostigmine 
+ diisopropylfluorophosphate 
+ diisopropylfluorophosphate 
0.02 36 
0.10 12 
2.00 0 
0.10 8 
20.00 22 
100.00 7 
0.10 0 
0.10 0 
0.02 0 
0.10 0 
2.00 0 
0.10 0 
0.02 29 
0.10 4 
2.00 0 
0.10 
0.10 
0.10 
0.10 
1 24 
138 
141 
108 
102 
91 
92 
86 
132 
142 
152 
88 
100 
128 
128 
129 
163 
pylpyrophosphoramide and phenyl boronic acid [30, 311 had 
no significant inhibitory effect on the peptidase activity 
(Table 2). Indeed there was an activation of the peptidase 
activity when eserine, Dip-F or phenyl boronic acid was used. 
The combined use of eserine or neostigmine with Dip-F also 
resulted in an activation of the peptidase activity (Table 2). 
Fig. 7 shows the effect of choline and its esters on both 
PsChE and peptidase activities. While choline did not signifi- 
cantly inhibit the enzyme activities, the choline esters mark- 
edly inhibited both PsChE and peptidase activities. The 
peptidase inhibition by choline esters observed by the 
spectrofluorimetric assay was confirmed by paper chromatog- 
raphy also. For a 1-h incubation period of the reaction (which 
was necessary for measuring the peptidase activity) with 
various concentrations of the choline esters, there was a 
parallel inhibition of both PsChE and peptidase activities 
(Fig. 7). A greater inhibition of PsChE activity after 10 min 
of incubation instead of 1 h was observed at all concentrations 
of choline esters presumably because of the enhanced loss of 
the choline esters by hydrolysis during 1 h (Fig. 7). That the 
unhydrolysed choline esters were the effective inhibitors of 
PsChE and peptidase was also evident from the facts that (a) 
choline alone was ineffective as an inhibitor and (b) the acyl 
part of the choline ester (acetate, propionate, butyrate, 
benzoate or succinate) alone or with choline was not inhibi- 
tory to either PsChE or peptidase activity (data not shown). 
DISCUSSION 
The identity of the peptidase with the purified human 
serum PsChE is based on the following observations. (a) Both 
PsChE and peptidase co-eluted with constant ratios of activity 
in the procainamide-Sepharose affinity column chromato- 
graphic procedure and showed identical characteristics in 
other types of affinity chromatography. (b) Both the activities 
comigrated on gel electrophoresis under non-denaturing 
conditions and both the activities corresponded to the only 
protein band detectable on the gel. (c) Both activities showed 
similar elution profiles on Sephadex G-200 gel filtration. 
(d) Both enzyme activities were coprecipitated at different 
dilutions of the antibody raised against purified PsChE 
enzyme. (e) Procainamide, which is a specific reversible in- 
hibitor of PsChE, inhibits PsChE more than 90% at 100 mM 
concentration but does not significantly inhibit the peptidase 
activity (Table 2). The fact that both peptidase and PsChE 
activities bind 100% to the procainamide-Sepharose column 
and that both are co-elutable with 0.05 M procainamide 
suggested that the peptidase must be associated with the 
PsChE enzyme. 
The inhibition characteristics of the peptidases are of in- 
terest. Several potent inhibitors of PsChE did not inhibit the 
peptidase activity (Table 2). These inhibitors are known to act 
at either the anionic or esteratic site of PsChE [30, 311. In fact 
a slight activation of the peptidase activity was observed with 
diisopropylfluorophosphate (Dip-F), eserine and phenyl 
boronic acid. It has been reported [30] that an aziridinium 
derivative, which alkylates the anionic site of AChE while 
inhibiting the hydrolysis of acetylcholine, can activate the 
hydrolysis of the very poor substrate indophenyl acetate. 
Apparently any inhibitor of PsChE whch acted only at either 
the anionic or esteratic site of PsChE did not inhibit the 
peptidase. Use of an anionic-site inhibitor (eserine or 
neostigmine) together with an esteratic-site inhibitor (Dip-F) 
also did not inhibit the peptidase activity. On the other hand 
inhbitors of PsChE which occupied both the anionic and 
esteratic sites, like the substrate analogues acetylcholine, 
butyrylcholine, propionylcholine, benzoylcholine o r  succinyl- 
choline, effectively inhibited the peptidase activity. Use of 
the acyl moiety of the choline esters (acetate, propionate, 
butyrate, benzoate or succinate) together with choline did not 
affect the peptidase. It was therefore evident that chemical 
entities which simultaneously occupied both esteratic and 
anionic sites and which were covalently linked to each other 
alone could bring about an inhibition of the peptidase activity. 
Under such conditions it is possible that a conformational 
alteration occurs resulting in the inhibition of a peptidase 
domain in the PsChE molecule. Evidence for alteration in 
conformational stability arising from structural modification 
of the active center in PsChE has been reported [32]. The 
tetrameric form of PsChE appears to be an asymmetric prolate 
ellipsoid [33] but the folded conformation of the enzyme is 
still unknown. Multistate denaturation of PsChE, caused by 
the possible unfolding and refolding of each domain in- 
dependently at different concentrations of urea, is also known 
The peptidase activity in PsChE was able to release amino 
acids from the carboxy terminal of several peptides. There 
was no evidence for removal of N-terminal amino acids. 
Blocking of the C-terminal amino acid by an amide group or 
ester group did not prevent the release of the C-terminal 
amino acids. This would suggest that the enzyme has an 
esterase, amidase and peptidase activity. The reported aryl 
[321. 
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Fig. 7. Inhibition of PsChE andpeptidase activities by choline and choline esters at different concentrations. Peptidase activity (0-0) was 
measured at 1 h of incubation in the presence of the inhibitors using Phe-Leu as substrate. PsChE activity was measured at 10 min of incubation 
in the presence of the inhibitor (0- - - -0) or after 1 h of preincubation with the inhibitor (0-0) 
acylamidase activity of PsChE is worth noting in this context 
[lo, 171. Lockridge found the release of N-terminal dipeptides 
from substance P by purified human serum PsChE [14]. Later 
work by Nausch and Heymann [17] showed that the dipeptidyl 
peptidase activity was a contaminant in the PsChE prepara- 
tion. Dip-F inhibited this dipeptidyl peptidase activity [17]. 
The present peptidase activity of PsChE reported by us is not 
inhibited by Dip-F. Lockridge observed the release of the 
amide -NH2 group of methionine from substance P by the 
purified PsChE but did not report the release of methionine 
and leucine from the C-terminal of substance P. This might 
be because of the use of EDTA by Lockridge in the reaction 
mixture [14]. In the present studies we have found that EDTA 
significantly inhibits the peptidase activity of PsChE with Phe- 
Leu, [Leu'lenkephalin or substance P as substrate. 
It is of interest that AChE from diverse sources has also 
been shown to have a peptidase activity [34]. The multiple 
types of reaction catalysed by AChE [9, 35, 361 may be 
attributed to the highly complex and possible multidomain 
nature of the AChE protein [37, 381. Recent evidence for 
several mRNAs, each generating distinct monomer of AChE 
[39 - 411, suggests that such multiple monomers present in 
AChE can also provide the multiple catalytic sites of AChE. 
PsChE, being a less complex protein containing four identical 
monomers, may be considered to have a specific domain re- 
sponsible for its peptidase activity. 
This work was supported by a grant from the Department of 
Science and Technology, India. R.B. is a teacher fellow on deputation 
under University Grants Commission (India) Undergraduate 
Development Scheme. 
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